SLRX vs UBER · $4.9M cap vs P/E 18, rev $52.02B
Salarius Pharmaceuticals Inc (SLRX) versus Uber Technologies Inc (UBER) — a side-by-side from cached financials, not a winner call.
Salarius Pharmaceuticals Inc (SLRX) is a biotechnology company listed on NASDAQ.
Uber Technologies Inc (UBER) is a software - application company listed on NYSE. It is led by Dara Khosrowshahi.
Latest reported SLRX revenue for 2023-03-31 was $0. Net income was -$5.3M. SLRX currently screens at market cap $4.9M.
Latest reported UBER revenue for 2025-12-31 was $52.02B. Net income was $10.05B. Revenue was up 18.3% from 2024-12-31 to 2025-12-31. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
SLRX currently screens at market cap $4.9M. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
Not investment advice. Open the SLRX and UBER stock pages for the full models.
Not investment advice.